Get All Access for FREEMarket News & Research,
Live Transcripts & Audio,
and a whole lot more…
$SIAL 1Q15 10-Q: Effective tax rate for the three months ended March 31, 2015 increased to 28% vs. 27.2% for the same period of 2014. The increase in the effective tax rate is primarily attributable to increases in uncertain tax positions which were partially offset by lower tax rates in certain foreign jurisdictions.
For full-year 2018, $WHR expects GAAP diluted EPS of $12.45-13.45 and ongoing diluted EPS of $14.50-15.50. The company expects to generate cash from operating activities of approx. $1.7-1.8Bil and free cash flow of approx. $1-1.1Bil for FY18.
$WHR reported a net loss of $268MM or $3.69 per share in 4Q17 compared to a net income of $180MM or $2.36 per share in 4Q16. This includes a one-time non-cash charge of approx. $420MM related to tax reform. 4Q17 ongoing diluted EPS was $4.10. Net sales were $5.7Bil, up 1% compared to the prior-year period.
$KMB plans to cut costs by $1.5Bil over the next four years, including slashing 5,000 to 5,500 jobs (about 12% of its workforce) and closing 10 facilities. This comes as the company reported a 22% YoY increase in profit for 4Q17, but only a slight uptick in sales. Excluding certain items, earnings were $1.57 per share, up 8% from a year ago.
For FY18, $HELE expects consolidated net sales revenue from continuing operations in the range of $1.440Bil to $1.463Bil, which implies sales growth of 2.3% to 4.0%. $HELE expects consolidated GAAP earnings per share for continuing operations of $5.42 to $5.63 and non-GAAP earnings per share for continuing operations in the range of $6.85 to $7.10.
$RAVN's BoD approved $25MM in stock repurchase authorization. With this additional authorization, $RAVN will have about $28MM remaining in its stock repurchase program. The board also approved a regular quarterly cash dividend of 13 cents a share, payable on Jan. 26, 2018 to shareholders of record on Jan. 12, 2018.
$CLX announced the official opening of a new manufacturing facility for the company's Home Care products. Named Atlanta West, the 258,000-sq.ft. facility is adjacent to the company's existing manufacturing facility, called Atlanta Main. The opening of Atlanta West has created about 100 jobs in Clayton County.
$ASH is combining its nutrition business with the ingredients processing expertise of the recently-acquired Pharmachem with the goal of expanding into the fast-growing global nutraceuticals market. The combined unit, which will be called Health and Wellness, will continue to report up through $ASH’s Specialty Ingredients segment.
$ASH plans to nominate Jerome Peribere as a new independent director for election at its upcoming 2018 Annual Meeting. If elected, it is also intended that Peribere will serve as a member of the compensation committee. George Schaefer Jr. will not be nominated for re-election to the board.
During 3Q18, $RAVN launched an initiative called Project Atlas. This is a strategic long-term investment to replace the existing enterprise resource planning platforms. Project Atlas is expected to take approx. three years to complete and cost between $8-10MM. In 3Q18, Project Atlas costs were approx. $300,000.
$RAVN reported net income of $12MM or $0.33 per share in 3Q18 versus $5.7MM or $0.16 per share in 3Q17. The increase in EPS was driven primarily by the improved operating performance in both Engineered Films and Aerostar. The impact of the CLI acquisition was neutral to EPS in 3Q18. Net sales were $101.3MM, up 39.7% versus last year.